Alembic Pharmaceuticals informs about press release

16 Jun 2021 Evaluate

Alembic Pharmaceuticals has informed the exchange that the Company's joint venture, Aleor Dermaceuticals has received US Food and Drug Administration (USFDA) Final Approval for Testosterone Topical Solution USP, 30 mg per pump actuation. The company has enclosed a press release on 16th June 2021, regarding the same.

The above information is a part of company’s filings submitted to BSE.

Alembic Pharma Share Price

762.55 -6.00 (-0.78%)
23-Jan-2026 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1631.65
Dr. Reddys Lab 1235.15
Cipla 1314.85
Zydus Lifesciences 881.95
Lupin 2137.15
View more..
Register Now to get our Free Newsletter & much more!

© 2026 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×